(Q67934936)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3171791%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Deferoxamine-induced growth retardation in patients with thalassemia major (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3171791%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3171791%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Francesco Cucca

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3171791%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

author name string

S De Virgiliis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3171791%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

F Frau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3171791%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

F Argiolu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3171791%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

G Diana

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3171791%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

A Varsi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3171791%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

G Sanna

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3171791%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

G Podda

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3171791%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

M Fodde

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3171791%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

language of work or name

English

0 references

publication date

1 October 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3171791%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

19 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3171791%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3171791%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3171791%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

661-669

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3171791%20AND%20SRC:MED&resulttype=core&format=json

Response to long-term deferoxamine therapy in thalassemia

19 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980375-5

Chelation therapy in β-thalassemia major. I. Intravenous and subcutaneous deferoxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980375-5

Survival and desferrioxamine in thalassaemia major.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980375-5

Early iron overload in beta-thalassaemia major: when to start chelation therapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980375-5

Ocular toxicity of high-dose intravenous desferrioxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980375-5

Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980375-5

Depletion of trace elements and acute ocular toxicity induced by desferrioxamine in patients with thalassaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980375-5

Clinical and Laboratory Studies on the Action of Desferrioxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980375-5

Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980375-5

The estimation of intestinal alkaline phosphatase in human blood serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980375-5

The determination of trace elements in human hair by atomic absorption spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980375-5

Leukocyte Alkaline Phosphatase (LAP) A Useful Marker of Zinc Status in β-Thalassemic Patients

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980375-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980375-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Studies of marginal zinc deprivation in rhesus monkeys. V. Fetal and infant skeletal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980375-5

Effect of zinc deficiency on bone collagenase and collagen turnover

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980375-5

10.1016/S0022-3476(88)80375-5

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3171791%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference